Cargando…

A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies

A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2K(b)-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Muses, Sofia, Morgan, Jennifer E., Wells, Dominic J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173493/
https://www.ncbi.nlm.nih.gov/pubmed/21935475
http://dx.doi.org/10.1371/journal.pone.0024826
_version_ 1782211971363373056
author Muses, Sofia
Morgan, Jennifer E.
Wells, Dominic J.
author_facet Muses, Sofia
Morgan, Jennifer E.
Wells, Dominic J.
author_sort Muses, Sofia
collection PubMed
description A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2K(b)-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks, without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for muscle disease.
format Online
Article
Text
id pubmed-3173493
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31734932011-09-20 A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies Muses, Sofia Morgan, Jennifer E. Wells, Dominic J. PLoS One Research Article A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2K(b)-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks, without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for muscle disease. Public Library of Science 2011-09-14 /pmc/articles/PMC3173493/ /pubmed/21935475 http://dx.doi.org/10.1371/journal.pone.0024826 Text en Muses et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Muses, Sofia
Morgan, Jennifer E.
Wells, Dominic J.
A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title_full A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title_fullStr A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title_full_unstemmed A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title_short A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
title_sort new extensively characterised conditionally immortal muscle cell-line for investigating therapeutic strategies in muscular dystrophies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173493/
https://www.ncbi.nlm.nih.gov/pubmed/21935475
http://dx.doi.org/10.1371/journal.pone.0024826
work_keys_str_mv AT musessofia anewextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies
AT morganjennifere anewextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies
AT wellsdominicj anewextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies
AT musessofia newextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies
AT morganjennifere newextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies
AT wellsdominicj newextensivelycharacterisedconditionallyimmortalmusclecelllineforinvestigatingtherapeuticstrategiesinmusculardystrophies